Drug Trial Radar · NCT04136171
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Last checked: Nov 20, 2026Latest source record: Sep 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,438
Actual
Start
Mar 13, 2020
Primary completion
Mar 25, 2026
Study completion Aug 12, 2026
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- Collaborators
- AstraZeneca
- First posted
- Oct 23, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy of eplontersen compared to placebo in participants with ATTR-CM receiving available standard of care (SoC).
Conditions
- Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Interventions
EplontersenDrug
Eplontersen by subcutaneous injection
PlaceboDrug
Eplontersen-matching placebo by subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite Outcome of Cardiovascular (CV) Mortality and Recurrent CV Clinical Events up to Week 140Time frame: Baseline up to Week 140
Locations
139 sites in 21 countries. Site status is shown where the registry gives one.
Mayo Clinic - Arizona
Phoenix, Arizona
Altman Clinical and Translational Research Institute Center for Clinical Research
La Jolla, California
Cedars-Sinai Medical Center
Los Angeles, California
University of California, San Francisco (UCSF) - Medical Center
San Francisco, California
Stanford Hospital
Stanford, California
University of Colorado Hospital - Anschutz Medical Campus
Aurora, Colorado
MedStar Washington Hospital Center
Washington D.C., District of Columbia
The George Washington Medical Faculty Associates - Foggy Bottom North Pavilion
Washington D.C., District of Columbia
Cleveland Clinic Florida
Weston, Florida
Piedmont Heart of Fayetteville
Atlanta, Georgia
Emory Heart and Vascular Center - Emory Clifton Campus
Atlanta, Georgia
Piedmont Heart of Fayetteville
Fayetteville, Georgia
Northwestern University
Chicago, Illinois
The University of Chicago Medical Center
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
Indiana University Health
Indianapolis, Indiana
University of Kansas Medical Center
Kansas City, Kansas
Tulane University Heart and Vascular Institute
New Orleans, Louisiana
Ochsner Health System
New Orleans, Louisiana
University of Maryland Medical Center
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
Boston University School of Medicine
Boston, Massachusetts
Henry Ford Health System
Detroit, Michigan
Minneapolis Heart Institute
Minneapolis, Minnesota
Mayo Clinic - Rochester
Rochester, Minnesota
Saint Luke's Hospital of Kansas City
Kansas City, Missouri
Barnes-Jewish Hospital
St Louis, Missouri
New York University Langone Cardiology Associates
New York, New York
Columbia University Irving Medical Center
New York, New York
Weill Cornell Medicine Cardiology
New York, New York
Laurelton Heart Specialists
Rosedale, New York
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Duke University Medical Center
Durham, North Carolina
Carl and Edyth Lindner Research Center at The Christ Hospital
Cincinnati, Ohio
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Cleveland Clinic Main Campus
Cleveland, Ohio
The Ohio State University College of Medicine
Columbus, Ohio
Oregon Health and Science University
Portland, Oregon
Lancaster General Hospital
Lancaster, Pennsylvania
Showing 40 of 139 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.